John M Evans plans sale of 25,000 BEAM shares

John M Evans has filed a notice to sell 25,000 shares of BEAM common stock on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

John M Evans has filed a notice to sell 25,000 shares of BEAM common stock on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The planned sale has an aggregate market value of $708,947.50, with 101,474,944 shares outstanding.

The 25,000 shares to be sold were acquired on January 30, 2026 via a stock option exercise from the issuer, paid in cash on the same date. During the past three months, Evans also sold 25,000 common shares on January 29, 2026 for gross proceeds of $734,582.50.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for BEAM by John M Evans show?

The Form 144 shows that John M Evans plans to sell 25,000 BEAM common shares on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $708,947.50, after acquiring the shares through a same-day stock option exercise paid in cash.

How many BEAM shares is John M Evans planning to sell under this Form 144?

John M Evans plans to sell 25,000 shares of BEAM common stock. These shares will be sold on the NASDAQ, with the filing listing an aggregate market value of $708,947.50 and Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the transaction.

How and when did John M Evans acquire the BEAM shares he plans to sell?

The 25,000 BEAM common shares were acquired on January 30, 2026 through a stock option exercise from the issuer. The filing states that payment for these shares was made in cash on the same date, directly linking acquisition and payment to the planned sale.

What prior BEAM share sales by John M Evans are disclosed in the last three months?

The filing discloses that John M Evans sold 25,000 BEAM common shares on January 29, 2026. These shares generated gross proceeds of $734,582.50, and this transaction is reported as part of the required three-month sale history for the person filing the notice.

Which broker and exchange are involved in John M Evans’s planned BEAM share sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The Form 144 lists the NASDAQ as the securities exchange where the 25,000 BEAM common shares will be sold.

How many BEAM shares are outstanding according to this Form 144 filing?

The Form 144 states that 101,474,944 BEAM common shares are outstanding. This figure provides context for the planned 25,000-share sale by John M Evans but is listed separately from the transaction details and market value amounts in the filing’s securities information section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/30/2026 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001786304
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BEAM THERAPEUTICS INC.
SEC File Number	001-39208
Address of Issuer	238 Main Street Cambridge MASSACHUSETTS 02142
Phone	(857) 327-8775
Name of Person for Whose Account the Securities are To Be Sold	JOHN M EVANS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	708947.50	101474944	01/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Stock Option Exercise	ISSUER			25000	01/30/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHN M EVANS 238 Main Street Cambridge MA 02142	Common	01/29/2026	25000	734582.50

144: Remarks and Signature

Remarks
Date of Notice	01/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John Martin Evans III
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)